Skip to main content
. 2013 Jan;11(1):108–122. doi: 10.2450/2012.0012-12

Figure 3A.

Figure 3A

Mean proportion of lifetime on chelation therapy* for patients enrolled in the EPIC study included in these analyses.

*Determined by the number of years the subject had already received chelation therapy divided by age at screening; regular or intermittent transfusions were not differentiated in the protocol.